Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05987761 · ClinicalTrials.gov registry record · NA

PRT for Adolescents With High Functioning Autism

A NA study of Autism and Child Development, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
76
Enrollment target
1
Study location

NCT05987761 is a NA study of Autism and Child Development that is actively recruiting participants, run by Stanford University. The registered enrollment target is 76 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (58% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05987761, a NA study of Autism and Child Development, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
76 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to identify improvement in behavioral and social function and changes in the brain following Pivotal Response Treatment (PRT) for Adolescents in highly verbal adolescents with autism spectrum disorder (ASD).

Interventions

  • BEHAVIORAL PRT for Adolescents

Study Locations (1)

California

  • Stanford Research Park - Palo Alto

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2023-09-01
Est. Completion 2026-08-31
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT05987761

The ClinicalTrials.gov registry entry for NCT05987761 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 104 other Autism trials with a reported enrollment target (58% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Autism appearing as the primary indexed condition, and to 1 intervention - of which PRT for Adolescents is the first listed.

NCT05987761 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05987761 about?

NCT05987761 is a clinical study titled "PRT for Adolescents With High Functioning Autism". The purpose of this study is to identify improvement in behavioral and social function and changes in the brain following Pivotal Response Treatment (PRT) for Adolescents in highly verbal adolescents with autism spectrum disorder (ASD).

What is the current status of trial NCT05987761?

This trial is currently recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2023-09-01. Estimated completion is 2026-08-31.

What conditions does trial NCT05987761 study?

This clinical trial studies the following conditions: Autism, Child Development, Developmental Disability, Behavior, Child, Behavior, Social.

What interventions are being tested in trial NCT05987761?

The interventions under investigation include: PRT for Adolescents (BEHAVIORAL).

Who is sponsoring clinical trial NCT05987761?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05987761 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.